GeoVax Labs (GOVX)
(Delayed Data from NSDQ)
$1.82 USD
+0.04 (2.25%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.84 +0.02 (1.10%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
GeoVax Labs Inc. [GOVX]
Reports for Purchase
Showing records 21 - 40 ( 67 total )
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
GeoVax presents Gedeptin Phase 1/2 clinical data at the AACR-AHNS Head and Neck Cancer Conference
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
GEO-CM04S1: Data Suggests Activity in Immune Compromised
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Gedeptin Phase 2 and CM04S1 Progress Notable; Reiterate Buy and $8 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Reports 1st Quarter 2023 - Funded Through Multiple Catalysts
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Poised to Reach Early Clinical and Discovery Milestones; Reiterate Buy and $8 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Buy Rated: $27.6 M in Cash at End of the Year
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Initiating with a Buy Rating & $4.00 Target
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
GeoVax and EmVenio Research Partner to Expand Clinical Trials of COVID-19 Booster Vaccine; Reiterate Buy and $8 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
High-Yield, High-Capacity MVA Manufacturing Makes Progress; Reiterate Buy and $8 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Rights Secured to Distribute and Commercialize Monkeypox Vaccine; Reiterate Buy and $8 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Plugging the Gap in Immune Protection; Initiate at Buy With an $8 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: GeoVax Labs Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G